# Statins and Lupus: Effects of Statins on Clinical Lupus Parameters, Serological Markers and Toll-like Receptors

> **NCT00519363** · PHASE1,PHASE2 · COMPLETED · sponsor: **The Center for Rheumatic Disease, Allergy, & Immunology** · enrollment: 15 (estimated)

## Conditions studied

- Systemic Lupus Erythematosus

## Interventions

- **DRUG:** atorvastatin

## Key facts

- **NCT ID:** NCT00519363
- **Lead sponsor:** The Center for Rheumatic Disease, Allergy, & Immunology
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2008-10
- **Final completion:** 2008-12
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2010-03-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00519363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00519363, "Statins and Lupus: Effects of Statins on Clinical Lupus Parameters, Serological Markers and Toll-like Receptors". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00519363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*